Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Polypharmacy
Interventions
BEHAVIORAL

TEAM Strategy

"1. Pharmacists will have read/write EHR access with established Epic security points~2. Pharmacists will initiate medication reconciliation activities by calling the patient for a Comprehensive Medication Review. Pharmacists will add notes in their medication list for the prescriber, requesting the removal or discontinuation of prescribed drugs that patients report they are not taking and adding medications omitted from the provider's list. The pharmacist will provide notifications via secured Epic messaging direct to prescribers of any patient concerns.~3. At 6 month if poor adherence is determined, the pharmacist will initiate Therapy Management Review which is a call from the pharmacist to the patient specifically about the medication(s) for which they have poor adherence. If necessary, the pharmacist will create notes and send an in-basket message to the prescriber.~4. The prescriber will make changes to the patient's EHR and/or contact the patient as they see fit."

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

Gordon and Betty Moore Foundation

OTHER

collaborator

Walgreens

INDUSTRY

collaborator

ACCESS Community Health Network

OTHER

lead

Northwestern University

OTHER

NCT04575155 - Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management | Biotech Hunter | Biotech Hunter